home.aspx
 
. https://www.europeanpharmaceuticalreview.com/51115/news/blog/biosimilars-future-pharma/
blog article
SHARESHARESHARE
BIOSIMILARS: THE FUTURE OF PHARMA? AN INTERVIEW WITH BOEHRINGER INGELHEIM
With biosimilars expected to account for 10% of the total biologics market by 2020, we caught up with Boehringer Ingelheim’s Senior VP and Head of Therapeutic Area Biosimilars. IVAN BLANARIK READ MORE